Clinical Trial Update: Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 interventional trial evaluating INCB 99280 in combination with ipilimumab in select solid tumors has been terminated. The study, sponsored by Incyte Cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Hepatocellular Carcinoma
• Melanoma
• Renal Cell Carcinoma

Drugs mentioned

• INCB 99280
• ipilimumab (ipilimumab)

Snippet

Sponsor: Incyte Corporation | Conditions: Melanoma, Hepatocellular Carcinoma (HCC) | Phase 1 | Status: TERMINATED